Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Diochot, S. et al. (1998) J. Biol. Chem. 273, 6744.
- BDS-II inhibits KV3.4 channels heterologously expressed in Xenopus oocytes.Left: Example traces before (red) and during (black) bath perfusion of 1 µM BDS-II (#B-450). Holding potential was -100 mV, test potential to 0 mV (100 ms) was delivered every 10 seconds. Recordings were made while perfusing ND 96 Buffer. Right: Time course for the experiment shown on the left. The vertical bar indicates the period of BDS-II perfusion.
- Alomone Labs BDS-II inhibits NaV1.7 channels stably expressed in HEK 293 cells.A. Time course of BDS-II (#B-450) action on NaV1.7 currents. Current amplitudes were plotted as a function of time. Membrane potential was held at -100 mV and cells were stimulated by a 20 ms voltage step to -20 mV. 100 nM BDS-II was perfused as indicated by the bar (green) for 80 sec. B. Superimposed examples of NaV1.7 channel current in the absence (control) and presence of 100 nM BDS-II (taken from the experiment in A).
- Diochot, S. et al. (1998) J. Biol. Chem. 273, 6744.
- Yeung, S.Y. et al. (2005) J. Neurosci. 25, 8735.
- Liu, P. et al. (2012) J. Neurophysiol. 107, 3155.
BDS-II is a 43 amino acid peptidyl toxin isolated from the sea anemone Anemonia sulcata venom. BDS-II was shown to be a specific KV3.4 blocker. BDS-II blocked 70% of the KV3.4 current in COS-transfected cells at a concentration of 2.8 µM. The blocking effect was rapid, direct and reversible1. Recently it was shown that BDS-II blocks other KV3 channels with similar potencies.2
The closely related BDS-I was shown to modulate voltage-gated Na+ channels. It enhanced TTX-sensitive Na+ channels (highly effective on NaV1.7 channels), and weakly inhibited TTX-resistant NaV channels3. As such, we showed that BDS-II also potently inhibits NaV1.7 channels (see Our Bioassay).
BDS-II (#B-450) is a highly pure, natural, and biologically active peptide toxin.
Applications
Citations
- Kanyshkova, T. et al. (2011) Pflugers Arch. 461, 545.
- Dallas, M.L. et al. (2008) Brain Res. 1189, 51.
- Iida, H. et al. (2005) Br. J. Pharmacol. 146, 49.
Specifications
Scientific Background
Related Products
Antibodies
- Anti-KV3.1b (KCNC1) Antibody (#APC-014)
- Anti-KV3.2 (KCNC2) Antibody (#APC-011)
- Anti-KCNC3 (KV3.3) Antibody (#APC-102)
- Anti-KCNC4 (KV3.4) Antibody (#APC-019)
- Anti-NaV1.7 (SCN9A) Antibody (#ASC-008)
- Anti-NaV1.7 (SCN9A)-ATTO Fluor-633 Antibody (#ASC-008-FR)
- Guinea pig Anti-NaV1.7 (SCN9A) Antibody (#AGP-057)
- Anti-NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-027)
Pharmacological tools
Explorer kits & Research packs
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us